Related Experiment Video

Updated: May 26, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

From prognosis to precision: interpreting HER2DX assay in early HER2-positive breast cancer

Yuhei Yamaguchi1, Yuki Kojima1, Kan Yonemori1

  • 1Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

Translational Cancer Research
|May 25, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
HER2DXHER2DX assaybreast cancerearly HER2-positive breast cancergenomic assay

More Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Concept Videos